butaclamol has been researched along with 3,4-dihydroxyphenylacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Farde, L; Hall, H; Halldin, C; Kopp, J; Magnusson, O; Sedvall, G | 1 |
2 other study(ies) available for butaclamol and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Benzazepines; Brain Chemistry; Butaclamol; Dopamine; Homovanillic Acid; Humans; Male; Middle Aged; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Tritium | 1994 |